Back to search results

Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants

Abroad (travel likely)RecruitingPHASE1

Conditions

Rheumatoid Arthritis · Systemic Lupus Erythematosus

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Research Site, Birmingham, Alabama, United States

  • Research Site, Fullerton, California, United States

  • Research Site, St Louis, Missouri, United States

  • Research Site, Allen, Texas, United States

  • Research Site, Mesquite, Texas, United States

  • Research Site, Birtinya, Australia

  • Research Site, Clayton, Australia

  • Research Site, Edegem, Belgium

  • Research Site, Leuven, Belgium

  • Research Site, Liège, Belgium

  • Research Site, Porto Alegre, Brazil

  • Research Site, Salvador, Brazil

  • Research Site, São Paulo, Brazil

  • Research Site, Beijing, China

  • Research Site, Chengdu, China

  • Research Site, Nanjing, China

  • Research Site, Bonn, Germany

  • Research Site, Jena, Germany

  • Research Site, Mainz, Germany

  • Research Site, München, Germany

  • Research Site, Münster, Germany

  • Research Site, Barcelona, Spain

  • Research Site, Córdoba, Spain

  • Research Site, Madrid, Spain

  • Research Site, Kaohsiung City, Taiwan

  • Research Site, Taichung, Taiwan

  • Research Site, Taipei, Taiwan

  • Research Site, Taoyuan, Taiwan

  • Research Site, Kyiv, Ukraine

  • Research Site, Ternopil, Ukraine

  • Research Site, Vinnytsia, Ukraine

  • Research Site, London, United Kingdom

  • Research Site, London, United Kingdom

View source on ClinicalTrials.gov(opens in a new tab)